A retrospective case series suggested that faricimab (Vabysmo) intravitreal injections may be associated with rare cases of ...

The effort represents a consortium of researchers from Penn Medicine, Penn Engineering, the University of Michigan Kellogg ...

Early results of a real-world study of faricimab demonstrated sustainable improvements in visual acuity and retinal anatomic ...

A number of recent clinical trials have suggested that gene therapy could help treat diseases of the eye that cause vision ...

Innovative research in monkeys has suggested that a human stem cell transplant may one day be a treatment for torn retinal ...

Retinal diseases are at the forefront of a quiet revolution in the realm of ophthalmology. Gene therapy, once a distant dream ...

A real-world study of an FDA-approved gene therapy for inherited retinal disease shows younger patients gain more visual ...

Series 7 was faster and tougher than past editions, too. For the first time, an Apple Watch had an official rating for dust ...

The upcoming M4 MacBook Pro may look a great deal, but Apple has something that will trump this new macOS-powered laptop.

Know someone who would love Medik8's bestselling Crystal Retinal wrinkle-fighting treatment and want to save money on it? This Christmas gift is a must for skincare fans ...

Follow the Company on its website, LinkedIn, or X. The Ocular Therapeutix logo and DEXTENZA ® are registered trademarks of Ocular Therapeutix, Inc. AXPAXLI™, PAXTRAVA™, ELUTYX™, and Ocular ...

Ocular Therapeutix's Elutyx drug delivery platform offers sustained long-term effects. See why OCUL stock is a Buy.